Viewing Study NCT04521569


Ignite Creation Date: 2025-12-24 @ 11:03 PM
Ignite Modification Date: 2025-12-25 @ 8:34 PM
Study NCT ID: NCT04521569
Status: COMPLETED
Last Update Posted: 2024-08-05
First Post: 2020-07-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System
Sponsor: University of Maryland, Baltimore
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: UVA-LAU-02
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View